Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Vancomycin | 12 | 2024 | 217 | 4.620 |
Why?
|
Anticoagulants | 15 | 2022 | 583 | 3.260 |
Why?
|
Anti-Bacterial Agents | 19 | 2024 | 2397 | 3.010 |
Why?
|
Acute Kidney Injury | 12 | 2022 | 608 | 2.550 |
Why?
|
Intensive Care Units, Pediatric | 18 | 2024 | 470 | 2.370 |
Why?
|
Anti-Arrhythmia Agents | 10 | 2021 | 218 | 2.240 |
Why?
|
Gentamicins | 7 | 2018 | 95 | 2.200 |
Why?
|
Heart Defects, Congenital | 20 | 2019 | 1803 | 2.150 |
Why?
|
Retrospective Studies | 86 | 2022 | 15998 | 2.100 |
Why?
|
Infant | 71 | 2024 | 12339 | 2.060 |
Why?
|
Warfarin | 7 | 2015 | 119 | 2.000 |
Why?
|
Child, Preschool | 74 | 2024 | 13880 | 1.970 |
Why?
|
Enoxaparin | 4 | 2017 | 42 | 1.740 |
Why?
|
Antithrombins | 4 | 2019 | 55 | 1.710 |
Why?
|
Infant, Newborn | 52 | 2022 | 8103 | 1.710 |
Why?
|
Child | 84 | 2024 | 24225 | 1.660 |
Why?
|
Dose-Response Relationship, Drug | 17 | 2019 | 1682 | 1.580 |
Why?
|
Diuretics | 7 | 2018 | 158 | 1.510 |
Why?
|
Critical Illness | 9 | 2024 | 591 | 1.500 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 8 | 2014 | 210 | 1.480 |
Why?
|
Heparin | 7 | 2022 | 227 | 1.460 |
Why?
|
Arrhythmias, Cardiac | 7 | 2021 | 457 | 1.430 |
Why?
|
Obesity | 9 | 2018 | 2227 | 1.420 |
Why?
|
Male | 101 | 2024 | 60040 | 1.400 |
Why?
|
Drug Monitoring | 7 | 2017 | 158 | 1.390 |
Why?
|
Digoxin | 3 | 2015 | 41 | 1.380 |
Why?
|
Adolescent | 62 | 2024 | 19095 | 1.330 |
Why?
|
Hospitals, Pediatric | 11 | 2019 | 780 | 1.290 |
Why?
|
Phenobarbital | 2 | 2019 | 36 | 1.260 |
Why?
|
Cardiovascular Agents | 3 | 2015 | 86 | 1.240 |
Why?
|
Female | 98 | 2024 | 65444 | 1.240 |
Why?
|
Cardiac Surgical Procedures | 12 | 2019 | 1099 | 1.190 |
Why?
|
Heart-Assist Devices | 7 | 2020 | 1023 | 1.180 |
Why?
|
Humans | 130 | 2024 | 123170 | 1.130 |
Why?
|
Phenytoin | 2 | 2018 | 63 | 1.120 |
Why?
|
Heart Diseases | 4 | 2017 | 483 | 1.090 |
Why?
|
Vasodilator Agents | 4 | 2015 | 203 | 1.090 |
Why?
|
Heart Failure | 12 | 2016 | 2125 | 1.070 |
Why?
|
Potassium | 3 | 2017 | 278 | 1.000 |
Why?
|
Tachycardia, Supraventricular | 4 | 2014 | 107 | 0.970 |
Why?
|
Critical Care | 5 | 2017 | 645 | 0.950 |
Why?
|
Furosemide | 4 | 2018 | 36 | 0.930 |
Why?
|
Acetaminophen | 3 | 2019 | 91 | 0.920 |
Why?
|
Extracorporeal Membrane Oxygenation | 5 | 2020 | 622 | 0.920 |
Why?
|
Anti-Infective Agents | 3 | 2021 | 266 | 0.890 |
Why?
|
Antihypertensive Agents | 3 | 2016 | 397 | 0.870 |
Why?
|
Practice Patterns, Physicians' | 6 | 2021 | 710 | 0.850 |
Why?
|
Seizures | 2 | 2018 | 871 | 0.840 |
Why?
|
Cardiotonic Agents | 6 | 2014 | 137 | 0.840 |
Why?
|
Kidney | 4 | 2018 | 1338 | 0.840 |
Why?
|
Creatinine | 14 | 2022 | 380 | 0.830 |
Why?
|
Length of Stay | 8 | 2019 | 1285 | 0.820 |
Why?
|
Medication Adherence | 2 | 2018 | 388 | 0.820 |
Why?
|
Drug Utilization | 2 | 2021 | 158 | 0.810 |
Why?
|
Diuresis | 4 | 2017 | 58 | 0.780 |
Why?
|
Texas | 19 | 2021 | 3547 | 0.780 |
Why?
|
Patient Readmission | 3 | 2016 | 365 | 0.780 |
Why?
|
Near Drowning | 1 | 2021 | 26 | 0.730 |
Why?
|
Drowning | 1 | 2021 | 36 | 0.720 |
Why?
|
Patient Admission | 4 | 2016 | 184 | 0.700 |
Why?
|
Antithrombin III | 2 | 2017 | 25 | 0.700 |
Why?
|
Antimicrobial Stewardship | 1 | 2021 | 84 | 0.690 |
Why?
|
Databases, Factual | 10 | 2020 | 1170 | 0.690 |
Why?
|
Infusions, Intravenous | 9 | 2018 | 533 | 0.680 |
Why?
|
Metabolic Clearance Rate | 6 | 2019 | 141 | 0.670 |
Why?
|
Nitroprusside | 3 | 2011 | 46 | 0.670 |
Why?
|
Ketorolac | 2 | 2012 | 17 | 0.670 |
Why?
|
Propensity Score | 2 | 2018 | 206 | 0.670 |
Why?
|
Antipyretics | 1 | 2019 | 9 | 0.670 |
Why?
|
Body Weight | 9 | 2022 | 999 | 0.660 |
Why?
|
Natriuretic Agents | 4 | 2007 | 31 | 0.660 |
Why?
|
Flecainide | 2 | 2021 | 22 | 0.650 |
Why?
|
Ibuprofen | 1 | 2019 | 42 | 0.650 |
Why?
|
Body Temperature | 1 | 2019 | 106 | 0.640 |
Why?
|
Ciprofloxacin | 2 | 2013 | 66 | 0.640 |
Why?
|
Area Under Curve | 4 | 2024 | 312 | 0.640 |
Why?
|
Models, Biological | 4 | 2021 | 1442 | 0.640 |
Why?
|
Heart Rate | 7 | 2018 | 585 | 0.630 |
Why?
|
Health Information Systems | 2 | 2020 | 32 | 0.620 |
Why?
|
Ideal Body Weight | 1 | 2018 | 3 | 0.620 |
Why?
|
Sodium Channel Blockers | 1 | 2018 | 24 | 0.620 |
Why?
|
Enalapril | 3 | 2014 | 18 | 0.620 |
Why?
|
Hyperkalemia | 2 | 2017 | 65 | 0.620 |
Why?
|
Alprostadil | 2 | 2015 | 27 | 0.610 |
Why?
|
Age Factors | 10 | 2019 | 2799 | 0.610 |
Why?
|
Drug Interactions | 5 | 2021 | 254 | 0.590 |
Why?
|
Hospitalization | 7 | 2018 | 1733 | 0.590 |
Why?
|
Blood Pressure | 7 | 2019 | 1315 | 0.590 |
Why?
|
Risk Factors | 21 | 2022 | 10010 | 0.590 |
Why?
|
Fenoldopam | 2 | 2008 | 11 | 0.590 |
Why?
|
Hypertension | 3 | 2016 | 1284 | 0.590 |
Why?
|
International Normalized Ratio | 4 | 2013 | 42 | 0.580 |
Why?
|
Pediatrics | 6 | 2022 | 1139 | 0.580 |
Why?
|
Urinary Tract Infections | 1 | 2021 | 293 | 0.570 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 2 | 2012 | 304 | 0.570 |
Why?
|
Postoperative Complications | 8 | 2019 | 3011 | 0.570 |
Why?
|
Spironolactone | 1 | 2017 | 18 | 0.570 |
Why?
|
Fibrinolytic Agents | 2 | 2017 | 198 | 0.570 |
Why?
|
Hypotension | 5 | 2019 | 175 | 0.570 |
Why?
|
Propranolol | 2 | 2014 | 128 | 0.570 |
Why?
|
Natriuretic Peptide, Brain | 4 | 2007 | 277 | 0.560 |
Why?
|
Sotalol | 2 | 2021 | 33 | 0.560 |
Why?
|
Chlorothiazide | 1 | 2016 | 12 | 0.560 |
Why?
|
Thromboembolism | 1 | 2017 | 83 | 0.550 |
Why?
|
Nephrons | 1 | 2016 | 20 | 0.550 |
Why?
|
Hypokalemia | 2 | 2017 | 41 | 0.550 |
Why?
|
Hospital Mortality | 8 | 2022 | 1009 | 0.550 |
Why?
|
Dexmedetomidine | 2 | 2014 | 44 | 0.540 |
Why?
|
Amiodarone | 2 | 2015 | 45 | 0.540 |
Why?
|
Cation Exchange Resins | 1 | 2016 | 2 | 0.540 |
Why?
|
Polystyrenes | 1 | 2016 | 14 | 0.540 |
Why?
|
Adrenergic beta-Antagonists | 4 | 2014 | 234 | 0.540 |
Why?
|
Drug-Related Side Effects and Adverse Reactions | 3 | 2014 | 255 | 0.540 |
Why?
|
Treatment Outcome | 25 | 2020 | 12116 | 0.540 |
Why?
|
Infusions, Parenteral | 2 | 2014 | 99 | 0.540 |
Why?
|
Time Factors | 15 | 2019 | 6204 | 0.540 |
Why?
|
Staphylococcal Infections | 2 | 2019 | 552 | 0.530 |
Why?
|
Equipment and Supplies, Hospital | 1 | 2015 | 10 | 0.520 |
Why?
|
Fractures, Bone | 1 | 2018 | 185 | 0.520 |
Why?
|
Hypnotics and Sedatives | 2 | 2014 | 133 | 0.520 |
Why?
|
Pain, Postoperative | 3 | 2022 | 255 | 0.500 |
Why?
|
Pseudomonas Infections | 2 | 2013 | 114 | 0.500 |
Why?
|
Overweight | 2 | 2015 | 358 | 0.490 |
Why?
|
Acetazolamide | 3 | 2018 | 30 | 0.480 |
Why?
|
Aortic Coarctation | 1 | 2016 | 105 | 0.470 |
Why?
|
Multivariate Analysis | 8 | 2017 | 1416 | 0.470 |
Why?
|
Academic Medical Centers | 1 | 2016 | 298 | 0.470 |
Why?
|
Thrombocytopenia | 2 | 2014 | 228 | 0.470 |
Why?
|
Incidence | 12 | 2019 | 3049 | 0.470 |
Why?
|
Thrombosis | 3 | 2015 | 519 | 0.470 |
Why?
|
Young Adult | 16 | 2020 | 8865 | 0.470 |
Why?
|
Vascular Surgical Procedures | 2 | 2019 | 565 | 0.470 |
Why?
|
Body Mass Index | 3 | 2015 | 1541 | 0.450 |
Why?
|
Case-Control Studies | 10 | 2018 | 3251 | 0.450 |
Why?
|
Microbial Sensitivity Tests | 3 | 2024 | 798 | 0.450 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2014 | 141 | 0.440 |
Why?
|
Mucocutaneous Lymph Node Syndrome | 1 | 2014 | 73 | 0.440 |
Why?
|
Venous Thrombosis | 1 | 2015 | 180 | 0.430 |
Why?
|
Administration, Oral | 5 | 2018 | 671 | 0.430 |
Why?
|
Pulmonary Embolism | 1 | 2015 | 172 | 0.420 |
Why?
|
Immunologic Factors | 1 | 2014 | 180 | 0.420 |
Why?
|
Hospital Information Systems | 1 | 2013 | 43 | 0.420 |
Why?
|
Cardiomyopathies | 3 | 2014 | 481 | 0.420 |
Why?
|
Cyanides | 2 | 2009 | 9 | 0.420 |
Why?
|
Potassium Chloride | 1 | 2012 | 54 | 0.420 |
Why?
|
Anticonvulsants | 1 | 2015 | 370 | 0.420 |
Why?
|
Medical Audit | 1 | 2013 | 99 | 0.410 |
Why?
|
Cohort Studies | 11 | 2020 | 4704 | 0.410 |
Why?
|
Postoperative Hemorrhage | 1 | 2013 | 86 | 0.410 |
Why?
|
Anesthetics | 1 | 2012 | 81 | 0.390 |
Why?
|
Down Syndrome | 1 | 2014 | 195 | 0.390 |
Why?
|
Linear Models | 6 | 2017 | 670 | 0.380 |
Why?
|
Anesthesiology | 1 | 2012 | 94 | 0.370 |
Why?
|
Surgical Wound Infection | 1 | 2013 | 260 | 0.360 |
Why?
|
Thoracic Surgical Procedures | 2 | 2011 | 92 | 0.360 |
Why?
|
Blood Coagulation | 1 | 2011 | 119 | 0.360 |
Why?
|
Ductus Arteriosus, Patent | 1 | 2012 | 141 | 0.360 |
Why?
|
Drug Dosage Calculations | 3 | 2013 | 19 | 0.350 |
Why?
|
Guideline Adherence | 1 | 2013 | 375 | 0.350 |
Why?
|
Follow-Up Studies | 8 | 2018 | 5046 | 0.350 |
Why?
|
United States | 11 | 2019 | 10629 | 0.340 |
Why?
|
Logistic Models | 5 | 2018 | 1796 | 0.340 |
Why?
|
Tertiary Care Centers | 4 | 2019 | 234 | 0.340 |
Why?
|
Anesthesia | 1 | 2012 | 211 | 0.340 |
Why?
|
Enteral Nutrition | 1 | 2011 | 250 | 0.330 |
Why?
|
Cardiology | 1 | 2014 | 472 | 0.310 |
Why?
|
Cardiac Catheterization | 2 | 2018 | 633 | 0.310 |
Why?
|
Dopamine Agonists | 1 | 2008 | 79 | 0.300 |
Why?
|
Pharmacy | 1 | 2007 | 13 | 0.290 |
Why?
|
Adenosine A2 Receptor Agonists | 2 | 2018 | 15 | 0.290 |
Why?
|
Alkalosis | 1 | 2007 | 23 | 0.290 |
Why?
|
Carbonic Anhydrase Inhibitors | 1 | 2007 | 24 | 0.280 |
Why?
|
Purines | 2 | 2018 | 107 | 0.280 |
Why?
|
Chlorides | 1 | 2007 | 104 | 0.280 |
Why?
|
Procainamide | 1 | 2006 | 4 | 0.280 |
Why?
|
Half-Life | 3 | 2019 | 156 | 0.280 |
Why?
|
Oliguria | 1 | 2006 | 19 | 0.280 |
Why?
|
Intensive Care Units | 3 | 2021 | 481 | 0.270 |
Why?
|
Emergency Service, Hospital | 4 | 2018 | 1073 | 0.270 |
Why?
|
Mineralocorticoid Receptor Antagonists | 1 | 2006 | 27 | 0.270 |
Why?
|
Adult | 19 | 2022 | 29034 | 0.270 |
Why?
|
Heart Transplantation | 7 | 2020 | 854 | 0.270 |
Why?
|
Heart Ventricles | 1 | 2011 | 765 | 0.270 |
Why?
|
Polycystic Kidney Diseases | 1 | 2006 | 30 | 0.260 |
Why?
|
Kidney Diseases | 4 | 2014 | 478 | 0.260 |
Why?
|
Acute Disease | 4 | 2018 | 1090 | 0.250 |
Why?
|
Factor Xa | 2 | 2017 | 17 | 0.250 |
Why?
|
Renal Insufficiency | 1 | 2007 | 233 | 0.250 |
Why?
|
Shock, Septic | 1 | 2006 | 146 | 0.240 |
Why?
|
Pyrazoles | 2 | 2018 | 303 | 0.240 |
Why?
|
Vomiting | 2 | 2016 | 115 | 0.240 |
Why?
|
Captopril | 3 | 2014 | 28 | 0.240 |
Why?
|
Coronary Care Units | 3 | 2016 | 36 | 0.240 |
Why?
|
Quality Assurance, Health Care | 1 | 2006 | 209 | 0.230 |
Why?
|
Nausea | 2 | 2015 | 97 | 0.230 |
Why?
|
Referral and Consultation | 1 | 2007 | 527 | 0.230 |
Why?
|
Respiration, Artificial | 2 | 2018 | 452 | 0.220 |
Why?
|
Injections, Intravenous | 2 | 2016 | 252 | 0.220 |
Why?
|
Electrocardiography | 4 | 2015 | 961 | 0.220 |
Why?
|
Paraspinal Muscles | 1 | 2022 | 7 | 0.210 |
Why?
|
Drug Therapy, Combination | 3 | 2017 | 1149 | 0.210 |
Why?
|
Blood Urea Nitrogen | 4 | 2006 | 70 | 0.200 |
Why?
|
Hemodynamics | 5 | 2018 | 848 | 0.200 |
Why?
|
Busulfan | 1 | 2021 | 44 | 0.200 |
Why?
|
Nerve Block | 1 | 2022 | 68 | 0.190 |
Why?
|
Residence Characteristics | 3 | 2021 | 271 | 0.190 |
Why?
|
Administration, Intravenous | 2 | 2019 | 143 | 0.190 |
Why?
|
Double Outlet Right Ventricle | 2 | 2011 | 21 | 0.190 |
Why?
|
Cardiovascular Diseases | 4 | 2019 | 1861 | 0.190 |
Why?
|
Renal Replacement Therapy | 1 | 2022 | 141 | 0.180 |
Why?
|
Patient Discharge | 2 | 2016 | 488 | 0.180 |
Why?
|
Amoxicillin | 1 | 2021 | 120 | 0.180 |
Why?
|
Ireland | 1 | 2020 | 27 | 0.180 |
Why?
|
Cystic Fibrosis | 1 | 2003 | 257 | 0.180 |
Why?
|
Myocarditis | 2 | 2013 | 119 | 0.180 |
Why?
|
Computer Simulation | 2 | 2022 | 637 | 0.180 |
Why?
|
Germany | 1 | 2020 | 87 | 0.180 |
Why?
|
Factor Xa Inhibitors | 3 | 2022 | 64 | 0.170 |
Why?
|
Respiratory Paralysis | 1 | 2019 | 7 | 0.170 |
Why?
|
Body Weights and Measures | 1 | 2019 | 41 | 0.170 |
Why?
|
Outpatients | 1 | 2021 | 254 | 0.170 |
Why?
|
Drug Overdose | 2 | 2013 | 65 | 0.170 |
Why?
|
Weight Gain | 2 | 2013 | 401 | 0.170 |
Why?
|
Gestational Age | 2 | 2018 | 1136 | 0.170 |
Why?
|
Asthma | 2 | 2017 | 746 | 0.170 |
Why?
|
Mitral Valve Annuloplasty | 1 | 2019 | 15 | 0.160 |
Why?
|
Hypoplastic Left Heart Syndrome | 2 | 2013 | 253 | 0.160 |
Why?
|
Diaphragm | 1 | 2019 | 97 | 0.160 |
Why?
|
Nafcillin | 1 | 2018 | 14 | 0.160 |
Why?
|
Clindamycin | 1 | 2018 | 40 | 0.160 |
Why?
|
Bupivacaine | 1 | 2018 | 21 | 0.160 |
Why?
|
Drug Evaluation | 1 | 2018 | 111 | 0.160 |
Why?
|
Hospital Costs | 2 | 2019 | 178 | 0.160 |
Why?
|
Analgesics, Non-Narcotic | 1 | 2019 | 68 | 0.150 |
Why?
|
Hematocrit | 1 | 2018 | 110 | 0.150 |
Why?
|
Serum Albumin | 1 | 2018 | 108 | 0.150 |
Why?
|
Tracheostomy | 1 | 2020 | 191 | 0.150 |
Why?
|
Statistics, Nonparametric | 3 | 2016 | 425 | 0.150 |
Why?
|
Decision Support Techniques | 1 | 2021 | 280 | 0.150 |
Why?
|
Chi-Square Distribution | 3 | 2014 | 586 | 0.150 |
Why?
|
Arterial Switch Operation | 1 | 2018 | 22 | 0.150 |
Why?
|
Myocardial Perfusion Imaging | 1 | 2018 | 57 | 0.150 |
Why?
|
Metolazone | 1 | 2017 | 5 | 0.150 |
Why?
|
Syringes | 1 | 2017 | 24 | 0.150 |
Why?
|
Hospital Charges | 1 | 2018 | 61 | 0.150 |
Why?
|
Anesthetics, Local | 1 | 2018 | 80 | 0.150 |
Why?
|
Peptide Fragments | 2 | 2014 | 748 | 0.150 |
Why?
|
Heart Valve Diseases | 1 | 2019 | 167 | 0.150 |
Why?
|
Conscious Sedation | 1 | 2018 | 62 | 0.150 |
Why?
|
Biological Variation, Population | 1 | 2017 | 26 | 0.150 |
Why?
|
Spinal Fusion | 1 | 2018 | 107 | 0.140 |
Why?
|
Esophageal Atresia | 1 | 2018 | 51 | 0.140 |
Why?
|
Tracheoesophageal Fistula | 1 | 2018 | 48 | 0.140 |
Why?
|
Marfan Syndrome | 1 | 2019 | 137 | 0.140 |
Why?
|
Mitral Valve | 1 | 2019 | 246 | 0.140 |
Why?
|
Hemorrhage | 2 | 2014 | 459 | 0.140 |
Why?
|
Drug Utilization Review | 2 | 2014 | 33 | 0.140 |
Why?
|
Body Composition | 1 | 2019 | 513 | 0.140 |
Why?
|
Fever | 1 | 2019 | 296 | 0.140 |
Why?
|
Epinephrine | 1 | 2017 | 174 | 0.140 |
Why?
|
Software | 2 | 2021 | 677 | 0.140 |
Why?
|
Hirudins | 2 | 2014 | 37 | 0.140 |
Why?
|
Kidney Function Tests | 2 | 2008 | 126 | 0.140 |
Why?
|
Administration, Rectal | 1 | 2016 | 8 | 0.140 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 1 | 2019 | 220 | 0.140 |
Why?
|
Azithromycin | 1 | 2016 | 44 | 0.140 |
Why?
|
Cardiac Output, Low | 2 | 2007 | 66 | 0.130 |
Why?
|
Consensus Development Conferences as Topic | 1 | 2016 | 39 | 0.130 |
Why?
|
Aortic Valve | 1 | 2019 | 428 | 0.130 |
Why?
|
Analysis of Variance | 3 | 2012 | 1011 | 0.130 |
Why?
|
Gastrointestinal Agents | 1 | 2016 | 60 | 0.130 |
Why?
|
Magnetic Resonance Imaging | 2 | 2018 | 3526 | 0.130 |
Why?
|
Birthing Centers | 1 | 2015 | 10 | 0.130 |
Why?
|
Solubility | 1 | 2015 | 131 | 0.130 |
Why?
|
Air Pollutants | 1 | 2017 | 101 | 0.130 |
Why?
|
Proportional Hazards Models | 1 | 2019 | 1305 | 0.130 |
Why?
|
Pediatric Obesity | 1 | 2021 | 380 | 0.130 |
Why?
|
Ambulatory Care | 2 | 2011 | 377 | 0.130 |
Why?
|
Delivery of Health Care | 1 | 2021 | 606 | 0.130 |
Why?
|
Thinness | 1 | 2015 | 68 | 0.120 |
Why?
|
Allergens | 1 | 2017 | 245 | 0.120 |
Why?
|
Analgesics | 1 | 2016 | 134 | 0.120 |
Why?
|
Institutional Practice | 1 | 2014 | 6 | 0.120 |
Why?
|
Pipecolic Acids | 1 | 2014 | 6 | 0.120 |
Why?
|
Morbidity | 1 | 2015 | 240 | 0.120 |
Why?
|
Bronchodilator Agents | 1 | 2016 | 153 | 0.120 |
Why?
|
Pharmaceutical Solutions | 1 | 2014 | 8 | 0.120 |
Why?
|
Therapeutic Equivalency | 1 | 2014 | 13 | 0.120 |
Why?
|
Community-Acquired Infections | 1 | 2016 | 241 | 0.120 |
Why?
|
Aorta, Thoracic | 1 | 2019 | 517 | 0.120 |
Why?
|
Heart Valve Prosthesis Implantation | 1 | 2019 | 425 | 0.120 |
Why?
|
Tablets | 1 | 2014 | 28 | 0.120 |
Why?
|
Drug Compounding | 1 | 2014 | 34 | 0.120 |
Why?
|
Databases as Topic | 1 | 2014 | 71 | 0.120 |
Why?
|
Health Status Disparities | 1 | 2017 | 220 | 0.120 |
Why?
|
Biological Availability | 1 | 2014 | 128 | 0.120 |
Why?
|
Analgesics, Opioid | 1 | 2018 | 401 | 0.110 |
Why?
|
Diarrhea | 1 | 2016 | 315 | 0.110 |
Why?
|
Postoperative Care | 2 | 2013 | 293 | 0.110 |
Why?
|
Practice Guidelines as Topic | 2 | 2014 | 1259 | 0.110 |
Why?
|
Risk Assessment | 4 | 2019 | 3329 | 0.110 |
Why?
|
Adrenal Cortex Hormones | 1 | 2016 | 317 | 0.110 |
Why?
|
Drug Therapy | 1 | 2014 | 87 | 0.110 |
Why?
|
Glomerular Filtration Rate | 2 | 2014 | 481 | 0.110 |
Why?
|
Pharmacy Service, Hospital | 1 | 2014 | 49 | 0.110 |
Why?
|
Angiotensin II Type 1 Receptor Blockers | 1 | 2014 | 51 | 0.110 |
Why?
|
Intraoperative Complications | 1 | 2015 | 175 | 0.110 |
Why?
|
Drug Resistance | 1 | 2014 | 256 | 0.110 |
Why?
|
Infant, Premature | 4 | 2014 | 798 | 0.110 |
Why?
|
Chylothorax | 1 | 2013 | 26 | 0.110 |
Why?
|
Medical Records | 2 | 2011 | 189 | 0.110 |
Why?
|
Chromatography, Liquid | 1 | 2014 | 191 | 0.110 |
Why?
|
Drug Administration Schedule | 2 | 2012 | 730 | 0.110 |
Why?
|
Anorexia | 1 | 2013 | 28 | 0.110 |
Why?
|
Ofloxacin | 1 | 2013 | 32 | 0.110 |
Why?
|
Citalopram | 1 | 2013 | 30 | 0.110 |
Why?
|
Nutritional Support | 1 | 2013 | 51 | 0.110 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2021 | 1196 | 0.110 |
Why?
|
Inappropriate Prescribing | 1 | 2013 | 41 | 0.110 |
Why?
|
Liver Function Tests | 1 | 2013 | 101 | 0.110 |
Why?
|
Levofloxacin | 1 | 2013 | 47 | 0.110 |
Why?
|
Cross-Over Studies | 1 | 2014 | 312 | 0.110 |
Why?
|
Aspirin | 2 | 2012 | 224 | 0.110 |
Why?
|
Recombinant Proteins | 2 | 2014 | 1390 | 0.100 |
Why?
|
Medicaid | 1 | 2015 | 245 | 0.100 |
Why?
|
Fasting | 1 | 2014 | 296 | 0.100 |
Why?
|
Age of Onset | 1 | 2014 | 581 | 0.100 |
Why?
|
Arginine | 1 | 2014 | 298 | 0.100 |
Why?
|
Respiratory Function Tests | 1 | 2013 | 194 | 0.100 |
Why?
|
Sulfonamides | 1 | 2014 | 259 | 0.100 |
Why?
|
Tandem Mass Spectrometry | 1 | 2014 | 227 | 0.100 |
Why?
|
Drug Prescriptions | 1 | 2014 | 216 | 0.100 |
Why?
|
Preoperative Period | 1 | 2012 | 82 | 0.100 |
Why?
|
Heart Arrest | 1 | 2016 | 341 | 0.100 |
Why?
|
Patient Care | 1 | 2012 | 100 | 0.100 |
Why?
|
Pseudomonas aeruginosa | 1 | 2013 | 164 | 0.100 |
Why?
|
Candidiasis | 1 | 2013 | 129 | 0.100 |
Why?
|
Abnormalities, Multiple | 1 | 2018 | 965 | 0.100 |
Why?
|
Whole Blood Coagulation Time | 1 | 2011 | 12 | 0.100 |
Why?
|
Contraindications | 1 | 2011 | 77 | 0.100 |
Why?
|
Aortic Aneurysm, Thoracic | 1 | 2019 | 660 | 0.090 |
Why?
|
Electrocardiography, Ambulatory | 1 | 2011 | 60 | 0.090 |
Why?
|
Ventilator Weaning | 1 | 2011 | 23 | 0.090 |
Why?
|
Pacemaker, Artificial | 1 | 2013 | 170 | 0.090 |
Why?
|
Prospective Studies | 5 | 2024 | 6028 | 0.090 |
Why?
|
Palliative Care | 2 | 2013 | 428 | 0.090 |
Why?
|
Labetalol | 1 | 2011 | 13 | 0.090 |
Why?
|
Serum | 1 | 2011 | 46 | 0.090 |
Why?
|
Tobramycin | 1 | 2010 | 23 | 0.090 |
Why?
|
Sex Factors | 1 | 2014 | 1255 | 0.090 |
Why?
|
Biomarkers | 4 | 2014 | 2942 | 0.090 |
Why?
|
Amikacin | 1 | 2010 | 24 | 0.090 |
Why?
|
Hydrocortisone | 2 | 2014 | 214 | 0.090 |
Why?
|
Fontan Procedure | 1 | 2012 | 182 | 0.090 |
Why?
|
Reoperation | 1 | 2013 | 819 | 0.090 |
Why?
|
Drug Resistance, Bacterial | 1 | 2013 | 362 | 0.090 |
Why?
|
Bacterial Infections | 1 | 2013 | 305 | 0.090 |
Why?
|
Prognosis | 3 | 2014 | 4505 | 0.080 |
Why?
|
Thiocyanates | 1 | 2009 | 10 | 0.080 |
Why?
|
Methemoglobinemia | 1 | 2009 | 8 | 0.080 |
Why?
|
Nitric Oxide Donors | 1 | 2009 | 23 | 0.080 |
Why?
|
Dopamine | 2 | 2014 | 275 | 0.080 |
Why?
|
Infant Nutritional Physiological Phenomena | 1 | 2011 | 191 | 0.080 |
Why?
|
Odds Ratio | 2 | 2013 | 1243 | 0.080 |
Why?
|
Genome, Viral | 1 | 2010 | 171 | 0.080 |
Why?
|
Partial Thromboplastin Time | 2 | 2022 | 45 | 0.080 |
Why?
|
Catheter Ablation | 1 | 2011 | 233 | 0.080 |
Why?
|
Acid-Base Imbalance | 1 | 2008 | 27 | 0.080 |
Why?
|
Acidosis | 1 | 2009 | 93 | 0.080 |
Why?
|
Superior Vena Cava Syndrome | 1 | 2008 | 17 | 0.070 |
Why?
|
Sepsis | 1 | 2012 | 478 | 0.070 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2016 | 715 | 0.070 |
Why?
|
Dietary Supplements | 1 | 2011 | 471 | 0.070 |
Why?
|
Cardiomyopathy, Dilated | 2 | 2006 | 214 | 0.070 |
Why?
|
Acecainide | 1 | 2006 | 2 | 0.070 |
Why?
|
Sodium Bicarbonate | 1 | 2007 | 52 | 0.070 |
Why?
|
Blood Chemical Analysis | 1 | 2007 | 77 | 0.070 |
Why?
|
Graft Rejection | 1 | 2010 | 582 | 0.070 |
Why?
|
Hospital Bed Capacity, 500 and over | 1 | 2006 | 15 | 0.070 |
Why?
|
Ticlopidine | 1 | 2006 | 28 | 0.070 |
Why?
|
Terminology as Topic | 1 | 2008 | 229 | 0.070 |
Why?
|
Milrinone | 1 | 2006 | 30 | 0.060 |
Why?
|
Fatal Outcome | 1 | 2006 | 357 | 0.060 |
Why?
|
Medical Errors | 1 | 2006 | 155 | 0.060 |
Why?
|
Socioeconomic Factors | 2 | 2017 | 869 | 0.060 |
Why?
|
Anti-Inflammatory Agents | 1 | 2005 | 280 | 0.050 |
Why?
|
Pilot Projects | 2 | 2018 | 1387 | 0.050 |
Why?
|
Electronic Health Records | 2 | 2021 | 699 | 0.050 |
Why?
|
Regression Analysis | 2 | 2014 | 773 | 0.050 |
Why?
|
Heart | 2 | 2018 | 725 | 0.050 |
Why?
|
Pharmacokinetics | 1 | 2021 | 16 | 0.050 |
Why?
|
Glutathione Transferase | 1 | 2021 | 153 | 0.050 |
Why?
|
Hypertension, Pulmonary | 1 | 2006 | 431 | 0.050 |
Why?
|
Agriculture | 1 | 2001 | 28 | 0.050 |
Why?
|
Neoplasms | 1 | 2014 | 2766 | 0.040 |
Why?
|
Severity of Illness Index | 3 | 2016 | 2836 | 0.040 |
Why?
|
Women's Health | 1 | 2001 | 130 | 0.040 |
Why?
|
Skin Temperature | 1 | 2019 | 19 | 0.040 |
Why?
|
Hospitals | 1 | 2021 | 397 | 0.040 |
Why?
|
Liposomes | 1 | 2018 | 168 | 0.040 |
Why?
|
Risk | 1 | 2020 | 749 | 0.040 |
Why?
|
Recurrence | 2 | 2014 | 1422 | 0.040 |
Why?
|
Wounds and Injuries | 1 | 2001 | 363 | 0.040 |
Why?
|
Documentation | 1 | 2018 | 115 | 0.040 |
Why?
|
Environmental Monitoring | 1 | 2017 | 64 | 0.030 |
Why?
|
Ozone | 1 | 2017 | 18 | 0.030 |
Why?
|
Pain Measurement | 1 | 2018 | 352 | 0.030 |
Why?
|
Transposition of Great Vessels | 1 | 2018 | 132 | 0.030 |
Why?
|
Air Pollution | 1 | 2017 | 67 | 0.030 |
Why?
|
Particulate Matter | 1 | 2017 | 69 | 0.030 |
Why?
|
Urban Population | 1 | 2017 | 221 | 0.030 |
Why?
|
Middle Aged | 2 | 2014 | 25966 | 0.030 |
Why?
|
Penicillins | 1 | 2016 | 154 | 0.030 |
Why?
|
Cephalosporins | 1 | 2016 | 138 | 0.030 |
Why?
|
Pneumonia, Bacterial | 1 | 2016 | 77 | 0.030 |
Why?
|
Exercise Test | 1 | 2016 | 250 | 0.030 |
Why?
|
Technetium Tc 99m Pentetate | 1 | 2014 | 9 | 0.030 |
Why?
|
Radionuclide Imaging | 1 | 2014 | 151 | 0.030 |
Why?
|
Vasopressins | 1 | 2014 | 43 | 0.030 |
Why?
|
Dobutamine | 1 | 2014 | 56 | 0.030 |
Why?
|
Infant, Extremely Low Birth Weight | 1 | 2014 | 38 | 0.030 |
Why?
|
Thoracic Duct | 1 | 2013 | 6 | 0.030 |
Why?
|
Octreotide | 1 | 2013 | 21 | 0.030 |
Why?
|
Pleurodesis | 1 | 2013 | 15 | 0.030 |
Why?
|
Meningitis | 1 | 2014 | 99 | 0.030 |
Why?
|
Bradycardia | 1 | 2014 | 59 | 0.030 |
Why?
|
Feasibility Studies | 1 | 2016 | 752 | 0.030 |
Why?
|
Radiopharmaceuticals | 1 | 2014 | 156 | 0.030 |
Why?
|
Ligation | 1 | 2013 | 132 | 0.030 |
Why?
|
Pseudomonas | 1 | 2013 | 11 | 0.030 |
Why?
|
Parenteral Nutrition, Total | 1 | 2013 | 114 | 0.030 |
Why?
|
Cross-Sectional Studies | 2 | 2018 | 3380 | 0.030 |
Why?
|
Survival Analysis | 1 | 2016 | 1469 | 0.030 |
Why?
|
Staphylococcus | 1 | 2013 | 69 | 0.030 |
Why?
|
Cardiopulmonary Resuscitation | 1 | 2016 | 313 | 0.030 |
Why?
|
Candida | 1 | 2013 | 75 | 0.030 |
Why?
|
Hypoglycemia | 1 | 2014 | 191 | 0.030 |
Why?
|
Infant, Premature, Diseases | 1 | 2014 | 238 | 0.020 |
Why?
|
Evidence-Based Medicine | 1 | 2016 | 619 | 0.020 |
Why?
|
Perioperative Period | 1 | 2012 | 49 | 0.020 |
Why?
|
Fatty Acids | 1 | 2013 | 338 | 0.020 |
Why?
|
Heterotaxy Syndrome | 1 | 2012 | 62 | 0.020 |
Why?
|
Nicardipine | 1 | 2011 | 18 | 0.020 |
Why?
|
Heart Septal Defects, Ventricular | 1 | 2012 | 133 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2013 | 1240 | 0.020 |
Why?
|
Monitoring, Physiologic | 1 | 2010 | 354 | 0.020 |
Why?
|
Graft Survival | 1 | 2010 | 524 | 0.020 |
Why?
|
Aldosterone | 1 | 2007 | 59 | 0.020 |
Why?
|
Endothelin-1 | 1 | 2007 | 39 | 0.020 |
Why?
|
Renin | 1 | 2007 | 89 | 0.020 |
Why?
|
Norepinephrine | 1 | 2007 | 175 | 0.020 |
Why?
|
Comorbidity | 1 | 2012 | 1497 | 0.020 |
Why?
|
Angioplasty, Balloon | 1 | 2008 | 161 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 2010 | 1585 | 0.020 |
Why?
|
Coronary Disease | 1 | 2010 | 638 | 0.020 |
Why?
|
Electrolytes | 1 | 2006 | 51 | 0.020 |
Why?
|
Equipment Failure | 1 | 2006 | 122 | 0.020 |
Why?
|
Survival Rate | 1 | 2010 | 1993 | 0.020 |
Why?
|
Clinical Protocols | 1 | 2005 | 236 | 0.010 |
Why?
|
Stroke Volume | 1 | 2006 | 448 | 0.010 |
Why?
|
Prevalence | 1 | 2010 | 2405 | 0.010 |
Why?
|
Aging | 1 | 2010 | 1172 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2008 | 2112 | 0.010 |
Why?
|
Stents | 1 | 2008 | 867 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2008 | 2848 | 0.010 |
Why?
|
Louisiana | 1 | 2001 | 135 | 0.010 |
Why?
|
Aged | 1 | 2001 | 19067 | 0.000 |
Why?
|